(Q45366869)

13 December 2017

Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection (English)

1 reference

13 December 2017

1 reference

1 reference

Sabrina Corbetta

1

0 references

Paolo Beck-Peccoz

8

object named as

Paolo Beck-Peccoz

0 references

Anna Spada

9

object named as

Anna Spada

1 reference

13 December 2017

Alessandro Redaelli

2

1 reference

13 December 2017

Massimo Pozzi

3

1 reference

13 December 2017

Giorgio Bovo

4

1 reference

13 December 2017

Laura Ratti

5

1 reference

13 December 2017

Elena Redaelli

6

1 reference

13 December 2017

Caterina Pellegrini

7

1 reference

13 December 2017

9 March 2011

1 reference

European Journal of Clinical Investigation

13 December 2017

1 reference

13 December 2017

41

1 reference

13 December 2017

8

1 reference

13 December 2017

898-905

1 reference

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

13 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Insulin resistance and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Hepatitis C virus infection: molecular pathways to metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adiponectin and its receptors in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adiponectin expression in human fetal tissues during mid- and late gestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

A catalogue of reporting guidelines for health research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Significance of serum adiponectin levels in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02498.X

10.1111/J.1365-2362.2011.02498.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference